Zeitschrift für Parasitenkunde

, Volume 58, Issue 2, pp 169–174 | Cite as

Schistosoma mansoni: Activity responses in vitro to praziquantel

  • C. J. Chavasse
  • M. C. Brown
  • D. R. Bell


The effects of praziquantel, a novel antischistosomal compound, on the activity of adultSchistosoma mansoni (Liverpool strain) in vitro were investigated.

Worm activity was modified at all concentrations of praziquantel. High concentrations (above 0.5 μg/ml) produced rapid paralysis, whilst low concentrations of praziquantel stimulated worm activity. It is concluded that such activity modification could lead to worm displacement in vivo.


Activity Modification Activity Response Schistosoma Praziquantel Schistosoma Mansoni 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andrews, P.: Pharmacokinetic studies with Droncit in animals using a biological assay. Vet. Med. Rev.2, 154–165 (1976)Google Scholar
  2. Andrews, P.: Praziquantel — a novel schistosomicide. Proceedings of British Society for Parasitology. Parasitology75, XVII-XVIII (1977)Google Scholar
  3. Brown, M.C., Chavasse, C.J., Norman, D.F., Bell, D.R.: Evoked response averaging techniques used to clarify the effect of drugs on the in vitro activity of schistosomes. Med. Biol. Eng.16, 597–598 (1978a)Google Scholar
  4. Brown, M.C., Norman, D.F., Bell, D.R., Chavasse, C.J.: A multichannel ultrasonic activity monitor for in vitro screening of antischistosomal drugs. Med. Biol. Eng.16, 408–418 (1978b)Google Scholar
  5. Chavasse, C.J., Brown, M.C., Bell, D.R.: Short-term effects of oxamniquine on the activity in vitro ofSchistosoma mansoni. Ann. Trop. Med. Parasitol.72, 293–295 (1978)PubMedGoogle Scholar
  6. Diekmann, H.W., Bühring, K.U.: The fate of praziquantel in the organism. III. Metabolism in rat, beagle dog and rhesus monkey. Eur. J. Drug Metab. Pharmakin.,2, 107–112 (1976)Google Scholar
  7. Gönnert, R., Andrews, P.: Praziquantel, a new broad-spectrum antischistosomal agent. Z. Parasitenkd.52, 129–150 (1977)CrossRefPubMedGoogle Scholar
  8. James, C., Webbe, G., Nelson, G.S.: The susceptibility to praziquantel ofSchistosoma haematobium in the baboon (Papio anubis) and ofS. japonicum in the vervet monkey (Cercopithecus aethiops). Z. Parasitenkd.52, 179–194 (1977)CrossRefPubMedGoogle Scholar
  9. Pax, R., Bennett, I.L., Fetterer, R.: A benzodiazepine derivative and praziquantel: Effects on musculature ofSchistosoma mansoni andSchistosoma japonicum. Arch. Pharmacol.304, 309–315 (1978)CrossRefGoogle Scholar
  10. Pellegrino, J., Lima-Costa, F.F., Carlos, M.A., Mello, R.T.: Experimental chemotherapy of schistosomiasis mansoni. XIII. Activity of praziquantel, an isoquinoline-pyrazino derivative, on mice, hamsters andCebus monkeys. Z. Parasitenkd.52, 151–168 (1977)CrossRefPubMedGoogle Scholar
  11. Steiner, K., Garbe, A.: The fate of praziquantel in the organism. II. Distribution in rats. Eur. J. Drug Metab. and Pharmakin.,2, 97–106 (1976)Google Scholar
  12. Steiner, K., Garbe, A., Diekmann, H.W., Nowak, H.: The fate of praziquantel in the organism. I. Pharmacokinetics in animals. Eur. J. Drug Metab. and Pharmakin.,2, 85–95 (1976)Google Scholar
  13. Webbe, G., James, C.: A comparison of the susceptibility to praziquantel ofSchistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum andS. matthei in hamsters. Z. Parasitenkd.52, 169–177 (1977)CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • C. J. Chavasse
    • 1
  • M. C. Brown
    • 2
  • D. R. Bell
    • 1
  1. 1.Department of Tropical MedicineLiverpool School of Tropical MedicineLiverpoolUK
  2. 2.Bioengineering and Medical Physics UnitUniversity of LiverpoolLiverpoolUK

Personalised recommendations